Directory Image
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Articles News & Society International
Premium Member
Enabling Organ-Specific Targeting Using Lnps

On June 29, ReCode Therapeutics, a gene therapy company, announced the closing of a $120 million Series B+ financing round. The round was led by Leaps by Bayer, the investment arm of Bayer, and...

Jerry Carter Jul 24, 2022
Premium Member
Successful Integration of Ipsc-Derived Human Photoreceptor Cells into the Retina After Transplantati

Eyes are the windows to the soul, but not everyone can have a bright pair of pupils. In the vision of blind patients, the world is not colorful, and blackness or nothingness is all they see in front...

Jerry Carter Jul 24, 2022
Premium Member
This Key Protein is Released to Promote Obesity-Related Liver Cancer Progression

In recent years, non-alcoholic fatty liver disease (NAFLD) has become a growing epidemic with the unhealthy lifestyle of people.A significant number of patients with non-alcoholic fatty liver disease...

Jerry Carter Jul 18, 2022
Premium Member
Tumor-Infiltrating T Cell System Classification Identifies Persistent Resident Memory T Cells Associ

T cells in tumor tissue are critical for both tumor immunosurveillance and elimination. CD8+ tumor infiltrating lymphocytes (TILs) can be used in pericyte therapy and are key targets for

Jerry Carter Jul 18, 2022
Premium Member
World's First Patient to Receive Moderna's Mrna Therapy for Genetic Disease

Scientists first identified and recognized the importance of mRNA in 1960, and it has since been studied and explored for use in vaccines and disease therapies. But until the end of 2020, the two mRNA...

Jerry Carter Jul 18, 2022
Premium Member
Nucleic Acid Drugs Can Achieve Functional Cure for Hepatitis B

Hepatitis B is a major global public health issue caused by hepatitis B virus (HBV) infection. More than 300 million people worldwide are currently infected with HBV, and around 600,000 people die...

Jerry Carter Jul 18, 2022
Premium Member
The New Protac, the First to Degrade Target Protein in Bacteria, Could Be Used As a New Antibacteria

Each year, bacterial infections kill hundreds of thousands of people, primarily in low- and middle-income countries. Given that only a few antibiotics have been approved during the last 50 years, the...

Jerry Carter Jul 18, 2022
Premium Member
Major Breakthrough in H. Pylori Research! This Beauty Factor is Actually a Cancer-Causing Accomplice

Since 2005, the World Gastroenterology Organization (WGO) has designated May 29 as World Gut Health Day to remind people to pay attention to the warnings from the intestines and to take care of their...

Jerry Carter Jun 12, 2022
Premium Member
Can Human Antibody Defense Withstand the Impact of Sars-Cov-2 Variants?

On May 18, 2022, a research team from the University of California, San Francisco and the affiliated Gladstone Institutes published in Nature a study entitled "Limited cross-variant immunity from...

Jerry Carter Jun 12, 2022
Premium Member
Mir-23B-3P is a Promising Therapeutic Target for Alzheimer's Disease

Alzheimer's disease (AD) is the most common neurodegenerative disease, characterized by memory loss, cognitive impairment and personality changes in the elderly. The main pathological features of the...

Jerry Carter Jun 12, 2022
Premium Member
Uncovering the Mechanism by Which One Inflammatory Disease Exacerbates Another

The immune system has a memory, which, typically, is triggered by previous exposures to hazards like bacteria or viruses, and it is useful. When internal causes like chronic inflammation stimulate...

Jerry Carter Jun 12, 2022
Premium Member
Why is It So Hard to Get an Hiv Vaccine?

Since the outbreak of the COVID-19 epidemic, several effective vaccines have been created at breakneck speed. However, more than 40 years after Michael Gottlieb, MD, a University of Rochester...

Jerry Carter Jun 12, 2022
Premium Member
More Than 100 Cases of "Monkeypox" Have Been Reported, Yet the Transmission Chain is Still Unknown!

Since May 13, 2022, 12 countries and territories in non-monkeypox endemic regions have reported confirmed cases of monkeypox to WHO, according to the WHO's official website. As of May 21, 92 confirmed...

Jerry Carter Jun 12, 2022
Premium Member
Boosting Cancer Treatment to a Golden Age

While cancer immunotherapy is in full swing, other areas are developing rapidly and will play a pivotal role in the future of cancer treatment, such as antibody-drug couples, protein...

Jerry Carter Jun 07, 2022
Premium Member
Antibody+ Protac: Degradation Agent-Antibody Conjugate (Dac)

Proteolysis-targeting chimeras (PROTACs), are heterobifunctional molecules that are rapidly revolutionizing the market landscape in biopharmaceuticals. These heterobifunctional compounds can degrade...

Jerry Carter Jun 07, 2022
1 Prior 6 7 8 9 10 . . . 73